Gary Titus
Overview
Gary Titus received an average of $2M in total compensation, including $264K in salary, at UroGen Pharma Ltd. from 2016 to 2018.
Source: SEC filing on April 26, 2019.
Related executives
We found ten more executives who work or worked at UroGen Pharma Ltd..
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
Jason Smith
UroGen Pharma Ltd.
General Counsel
Don Kim
UroGen Pharma Ltd.
Chief Financial Officer
Molly Henderson
UroGen Pharma Ltd.
Chief Financial Officer
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
Mark Schoenberg
UroGen Pharma Ltd.
Chief Medical Officer
Stephen Mullennix
UroGen Pharma Ltd.
Chief Operating Officer
Ron Bentsur
UroGen Pharma Ltd.